Follicular Lymphoma
Showing NaN - NaN of 42
Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)
Not yet recruiting
- Follicular Lymphoma
- Mosunetuzumab
- Tazemetostat Pill
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Aug 8, 2023
Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)
Not yet recruiting
- Follicular Lymphoma
- +3 more
- Tazemetostat Pill
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023
Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +2 more
-
New York, New YorkWeill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +11 more
- Zilovertamab vedotin
-
Duarte, California
- +13 more
Jan 12, 2023
Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (tafasitamab, rituximab, lenalidomide)
Recruiting
- Follicular Lymphoma
- Marginal Zone Lymphoma
- tafasitamab
- +3 more
-
Concord, California
- +255 more
Dec 1, 2022
Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene
Active, not recruiting
- Non-Hodgkin Lymphoma
- +4 more
- JCAR017 (lisocabtagene maraleucel) single-dose schedule
- JCAR017 (lisocabtagene maraleucel) 2-dose schedule
-
Birmingham, Alabama
- +24 more
Nov 21, 2022
DLBCL, Follicular Lymphoma Trial in United States (Epcoritamab)
Recruiting
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
-
Fountain Valley, California
- +38 more
Jul 27, 2022
DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)
Terminated
- Diffuse Large B-Cell Lymphoma
- +4 more
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +167 more
Jul 20, 2022
Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma Trial in United
Recruiting
- Relapsed Chronic Lymphocytic Leukemia
- +4 more
-
Phoenix, Arizona
- +7 more
Apr 28, 2022
DLBCL, Follicular Lymphoma Trial in Worldwide (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, rituximab
Recruiting
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
- rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
- +7 more
-
Birmingham, Alabama
- +61 more
Apr 13, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- +6 more
-
Duarte, California
- +165 more
Mar 24, 2022
Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in United States (dietary supplement, biological,
Active, not recruiting
- Follicular Lymphoma
- +3 more
- Vitamin D
- +2 more
-
Miami, Florida
- +6 more
Mar 6, 2022
Follicular Lymphoma, Endometrial Cancer Trial in New York (Copanlisib, Ketogenic Diet)
Recruiting
- Follicular Lymphoma
- Endometrial Cancer
- Copanlisib
- Ketogenic Diet
-
New York, New York
- +2 more
Nov 24, 2021
Follicular Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Idasanutlin, Obinutuzumab, Venetoclax)
Terminated
- Follicular Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Idasanutlin
- +3 more
-
Aurora, Colorado
- +20 more
Dec 5, 2021
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
DLBCL, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spain, United States (Loncastuximab Tesirine and Durvalumab)
Terminated
- Diffuse Large B-Cell Lymphoma
- +2 more
- Loncastuximab Tesirine and Durvalumab
-
Birmingham, Alabama
- +13 more
Sep 28, 2021